CPL-Pharma:
Unlock your potential
Empowering growth through CDMO-CMO Partnership
We accelerate the journey from molecule to market by delivering end-to-end CDMO solutions, ensuring faster, safer, and smarter access to life-changing therapies worldwide.
Years of Excellence
Global Clients
Countries Served
Driving Innovation from Discovery to Delivery
About Us
CPL-Pharma (Division of Cadila Pharmaceuticals Ltd.) is a science-led contract research, development, and manufacturing organization (CRDMO) committed to accelerating the journey from molecule to market to accelerating the journey from molecule to market. We offer product and services—from early-stage discovery to commercial manufacturing—we help bring life-changing therapies to patients.
At the forefront of pharmaceutical innovation, we are a trusted API CDMO partner—supporting global healthcare companies in bringing life-saving therapies to patients faster, safer, and smarter.
Vision
To be recognized as a global leader in API and CDMO services, delivering breakthrough healthcare solutions through science, innovation, and operational excellence.
Values
We are driven by Integrity, Innovation, Sustainability, and Customer-Centric Collaboration—principles that guide our every decision and partnership.
Promise
With global delivery capabilities and a collaborative mindset, we ensure long-term partnerships built on trust, innovation, and a shared commitment to success.
Commercial Manufacturing
We offer product and services from early-stage discovery to commercial manufacturing. We help bring life-changing therapies to patients.
Regulatory Compliance
Development and manufacturing of Active Pharmaceutical Ingredients from process development to commercial-scale production, under strict regulatory compliance.
Pharmaceutical Innovation
At the forefront of pharmaceutical innovation, we are a trusted CDMO partner offering large scale manufacturing for API, intermediates and KSM
Our Facilities
Our facilities are approved by global regulatory agencies like USFDA, EDQM (Europe), TGA(Australia), PMDA (Japan), KFDA (Korea), WHO (Geneva) and ANVISA (Brazil).
End-to-End Support
Seamless support from preclinical research to full-scale commercialization.
Innovative Manufacturing
Advanced technologies for APIs, biologics, and complex generics.
Regulatory Expertise
Strict compliance with USFDA, EMA, WHO, MHRA, PMDA, and more.
Cost Efficiency
Digitally integrated Industry 4.0 facilities with AI-enabled systems.
Manufacturing Facilities
We operate two advanced manufacturing facilities (Unit 1 & Unit 2), approved by USFDA and EU-GMP, delivering:
- Flexible, compliant, and scalable CDMO solutions
- Global quality standards trusted by innovators and generic partners
- Robust infrastructure enabling seamless technology transfer and reliable commercial supply
Greenfield API Facility (DCS-Controlled)
Our newest state-of-the-art greenfield API facility (Unit-3), is now operational, equipped with advanced Distributed Control System (DCS) technology. This facility is designed to:
- Produce APIs with high purity and consistency
- Ensure greater precision, process efficiency, and safety
- Reduce environmental impact through sustainable operations
- Provide the capacity and scalability to meet increasing global customer demand
Know More About Facilities
Research Capabilities
Our state of the art R&D facility is located in India with more than 175 highly experienced scientists. The R&D facility is equipped with Synthetic Chemistry Labs, Process Engineering Labs, Analytical Labs and Patent Cell. It has all the sophisticated instruments like XRD, GC-MS, LC-MS, HPLC, GC, NMR, Malvern Mastersizer 3000, DSC and TGA. We have a dedicated regulatory team with extensive experience of handling global regulatory filings and quality management system.
- Core Synthetic Expertise
- Green Chemistry & Bio-Catalysis
- Process Development & Analytical Excellence
- Key Differentiators
API CDMO specializes in the development and manufacturing
API Research
Our approach to faster development of technology drug substance (API)
- Robust, scalable and first time right process development
- Green chemistry and engineering principles
- Quantification & Control of Nitrosoamines & NDSRIs
- Solid state chemistry/engineering for identification & quantification of Polymorphic forms
- Techniques to meet customer specific requirements e.g. particle size, impurities
Sustainable Future
Sustainability & ESG Commitment
We are committed to sustainable growth through responsible environmental, social, and governance (ESG) practices. We are dedicated to creating a positive impact through various key initiatives undertaken. We have developed a strategic ESG roadmap to drive sustainability across our operations. We’re extending our GRI-based indicators and aligning disclosures with international frameworks and consortia (Sustainability Accounting & Standards Board (SASB), Bio Pharma Sustainability Roundtable, Pharma Supply Chain Initiative (PSCI)) including the EU’s Corporate Sustainability Reporting Directive (CSRD).
Contact Us
Contact Us To Know More
Whether you are looking for end-to-end API development, CDMO services, or research collaboration—our team is here to help.